Colestyramine
Colestyramine structure
|
Common Name | Colestyramine | ||
|---|---|---|---|---|
| CAS Number | 11041-12-6 | Molecular Weight | 331.923 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C21H30ClN | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | N/A | |
|
A review of the diagnosis and treatment of Ochratoxin A inhalational exposure associated with human illness and kidney disease including focal segmental glomerulosclerosis.
J. Environ. Public Health 2012 , 835059, (2012) Ochratoxin A (OTA) exposure via ingestion and inhalation has been described in the literature to cause kidney disease in both animals and humans. This paper reviews Ochratoxin A and its relationship to human health and kidney disease with a focus on a possibl... |
|
|
Using resin to generate a non-invasive intestinal bile-depleted rat model was unsuccessful.
Eur. J. Pharm. Sci. 47(2) , 347-51, (2012) The purpose of this study was to evaluate if a rat model, based upon co-administration of the anion-exchanging resin, cholestyramine, could replace surgery when evaluating the importance of bile on drug absorption. Two different formulations were used for the... |
|
|
[Antidiarrheal drugs for chronic diarrhea].
Dtsch. Med. Wochenschr. 138(45) , 2309-12, (2013) Chronic diarrhea can be caused by multiple disease entities. Basic diagnostic tests are required in order to administer specific therapies whenever possible. If no specific treatment can be used, a symptomatic management should be initiated in order to preven... |
|
|
Functional diarrhea.
Gastroenterol. Clin. North Am. 41(3) , 629-37, (2012) Chronic diarrhea is a frequent and challenging problem in clinical medicine. In a considerable subgroup of these, no underlying cause is identified and this is referred to as functional diarrhea. A consensus definition for functional diarrhea is based on loos... |
|
|
[Intrahepatic cholestasis of pregnancy].
Akush. Ginekol. (Sofiia.) 52(1) , 35-41, (2013) The contemporary aspects of obstetric cholestasis including its etiology, pathogenesis, molecular basis, diagnosis, therapy and obstetric management are presented. The possible maternal and fetal complications are discussed too. |
|
|
Cholestyramine for thyrotoxicosis?
J. Fam. Pract. 62(4) , E1-2, (2013)
|
|
|
Oral cholestyramine is not an effective treatment for uncomplicated erythropoietic protoporphyria.
J. Am. Acad. Dermatol. 67(6) , 1383-4, (2012)
|
|
|
Homozygous familial hypercholesterolaemia.
Lancet 379(9823) , 1330, (2012)
|
|
|
Cost-effectiveness of child-focused and parent-focused interventions in a child anxiety prevention program.
J. Anxiety Disord. 26(2) , 287-96, (2012) In this study, the cost-effectiveness of three indicated anxiety prevention strategies was examined from a societal perspective. Children (aged 8-12) were recruited via primary schools, selecting children scoring as high-anxious on an anxiety screening questi... |
|
|
The challenge of cholestatic pruritus.
Acta Gastroenterol. Belg. 75(4) , 399-404, (2012) Pruritus can be the dominant symptom of cholestatic liver disease but is difficult to treat since unraveling its pathophysiology is a great challenge. Serum autotaxin activity correlates with pruritus intensity, but its causal relationship, expression pattern... |